AS Latvijas Juras medicinas centrs (MU:UOM) — Market Cap & Net Worth
Market Cap & Net Worth: AS Latvijas Juras medicinas centrs (UOM)
AS Latvijas Juras medicinas centrs (MU:UOM) has a market capitalization of $5.92 Million (€5.06 Million) as of September 19, 2026. Listed on the MU stock exchange, this Germany-based company holds position #28352 globally and #2436 in its home market, demonstrating a -8.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AS Latvijas Juras medicinas centrs's stock price €7.40 by its total outstanding shares 800000 (800.00K). Also see balance sheet size of AS Latvijas Juras medicinas centrs for a full breakdown of the balance sheet.
AS Latvijas Juras medicinas centrs Market Cap History: 2015 to 2026
AS Latvijas Juras medicinas centrs's market capitalization history from 2015 to 2026. Data shows growth from $2.54 Million to $6.92 Million (12.62% CAGR). Also see UOM operating cash flow for how efficiently the company converts equity into cash flow.
AS Latvijas Juras medicinas centrs Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AS Latvijas Juras medicinas centrs's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check AS Latvijas Juras medicinas centrs (UOM) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.81x
AS Latvijas Juras medicinas centrs's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
34.54x
AS Latvijas Juras medicinas centrs's market cap is 34.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.63 Million | $6.04 Million | -$98.23K | 0.27x | N/A |
| 2017 | $3.05 Million | $6.33 Million | $223.95K | 0.48x | 13.64x |
| 2018 | $4.10 Million | $6.67 Million | $34.62K | 0.61x | 118.37x |
| 2019 | $4.17 Million | $7.27 Million | $164.16K | 0.57x | 25.38x |
| 2020 | $6.76 Million | $7.08 Million | $273.56K | 0.95x | 24.71x |
| 2021 | $11.59 Million | $9.36 Million | $880.26K | 1.24x | 13.16x |
| 2022 | $11.02 Million | $9.70 Million | $625.73K | 1.14x | 17.62x |
| 2023 | $9.91 Million | $9.85 Million | -$624.25K | 1.01x | N/A |
| 2024 | $6.36 Million | $10.19 Million | $185.16K | 0.62x | 34.35x |
| 2025 | $8.32 Million | $10.29 Million | $241.00K | 0.81x | 34.54x |
Competitor Companies of UOM by Market Capitalization
Companies near AS Latvijas Juras medicinas centrs in the global market cap rankings as of September 19, 2026. Review tangible net worth ratio of AS Latvijas Juras medicinas centrs to assess the quality of the company's equity after excluding intangible assets.
Key companies related to AS Latvijas Juras medicinas centrs by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #291 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #916 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #995 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1233 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #291 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $427.71 |
| #916 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.92 |
| #995 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1233 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $261.99 |
AS Latvijas Juras medicinas centrs Historical Marketcap From 2015 to 2026
Between 2015 and today, AS Latvijas Juras medicinas centrs's market cap moved from $2.54 Million to $ 6.92 Million, with a yearly change of 12.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.92 Million | -16.85% |
| 2025 | €8.32 Million | +30.88% |
| 2024 | €6.36 Million | -35.85% |
| 2023 | €9.91 Million | -10.08% |
| 2022 | €11.02 Million | -4.85% |
| 2021 | €11.59 Million | +71.41% |
| 2020 | €6.76 Million | +62.26% |
| 2019 | €4.17 Million | +1.65% |
| 2018 | €4.10 Million | +34.17% |
| 2017 | €3.05 Million | +87.61% |
| 2016 | €1.63 Million | -36.03% |
| 2015 | €2.54 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of AS Latvijas Juras medicinas centrs was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.92 Million USD |
| MoneyControl | $5.92 Million USD |
| MarketWatch | $5.92 Million USD |
| marketcap.company | $5.92 Million USD |
| Reuters | $5.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AS Latvijas Juras medicinas centrs
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more